malt1 inhibitor abbv-525
Generic: MALT1 Inhibitor ABBV-525
malt1 inhibitor abbv-525: 1 clinical trial tracked.
malt1 inhibitor abbv-525 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about malt1 inhibitor abbv-525, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies
Primary endpoint: Number of Participants With Adverse Events (AE)
InterventionalRandomizedopen150 targetStarted 2023-04Completion 2029-0739 sites · Australia, Belgium, France, Germany…AbbVie